Numerous studies have suggested that the mitogen-activated protein kinases (MAPK) pathway (also known as the RAS-RAF-MEK-ERK pathway) plays a role in osteosarcoma metastasis, however the functional consequences and therapeutic implications of its activation have not be elucidated [12–20]. Here, MAP2K7 is linked to osteosarcoma.